Related Experiment Video
Updated: Jul 2, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Speeding up the evaluation of new agents in cancer
Mahesh K B Parmar1, Friederike M-S Barthel, Matthew Sydes
1Clinical Trials Unit, London, UK. mp@ctu.mrc.ac.uk
Abstract:
Despite both the increase in basic biologic knowledge and the fact that many new agents have reached various stages of development during the last 10 years, the number of new treatments that have been approved for patients has not increased as expected. We propose the multi-arm, multi-stage trial design as a way to evaluate treatments faster and more efficiently than current standard trial designs. By using intermediate outcomes and testing a number of new agents (and combinations) simultaneously, the new design requires fewer patients. Three trials using this methodology are presented.
Insights
New multi-arm, multi-stage clinical trial designs can accelerate the evaluation of novel treatments and reduce patient numbers. This approach efficiently tests multiple agents simultaneously using intermediate outcomes.
Area of Science:
- Clinical trial methodology
- Drug development and evaluation
Background:
- Despite advances in biologic knowledge and drug development, the approval of new patient treatments has lagged.
- Current standard trial designs face limitations in speed and efficiency for evaluating numerous new therapeutic agents.
Purpose of the Study:
- To propose and present the multi-arm, multi-stage trial design as an innovative solution for faster and more efficient treatment evaluation.
- To demonstrate the practical application of this novel trial methodology.
Main Methods:
- Implementing a multi-arm, multi-stage trial design.
- Utilizing intermediate outcomes to assess treatment efficacy.
- Simultaneously testing multiple new agents and their combinations.
Main Results:
- The proposed design requires fewer patients compared to standard trial designs.
- Successfully applied the methodology in three distinct clinical trials.
- Demonstrated increased efficiency in treatment evaluation.
Conclusions:
- The multi-arm, multi-stage trial design offers a significant improvement in evaluating new treatments.
- This methodology facilitates faster drug development and approval processes.
- The presented trials showcase the viability and benefits of this innovative approach.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

